Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital
BRIEF-Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital Nov 12 (Reuters) - FRESENIUS SE & CO. KGAA FREn.DE:
COMPLETES SALE OF 13.4 MILLION FRESENIUS MEDICAL CARE SHARES AT €39.00 PER SHARE, RAISING APPROXIMATELY €524 MILLION
SETTLEMENT IS EXPECTED ON 16 NOVEMBER 2026
ANTICIPATED BOOK GAIN IN LOW TO MID DOUBLE-DIGIT MILLION EURO RANGE WILL BE REFLECTED IN Q4 2026 RESULTS
REMAINS SUBJECT TO A LOCK-UP ON ITS REMAINING SHARES OF 90 DAYS
PROCEEDS WILL BE USED CONSISTENTLY WITH STATED CAPITAL ALLOCATION PRIORITIES SET OUT UNDER #FUTUREFRESENIUS
FINANCIAL INVESTMENT IN FRESENIUS MEDICAL CARE REDUCES FROM APPROXIMATELY 25 PER CENT TO APPROXIMATELY 20 PER CENT OF ISSUED SHARE CAPITAL
Source text: ID:nEQ2ZX5rBa
Further company coverage: [FREn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Fresenius SE & Co. KGaA
See all newsEurope Research Roundup: Essilorluxottica, Orsted, Swiss Life
FMC seen down as Fresenius cuts stake to 20%
Europe Research Roundup: Banco BPM, Sartorius, TP
Germany's Fresenius cuts FMC stake to 20%
Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital